With decades of combined experience working within Europe’s highly regulated medicinal Cannabis and Pharmaceutical sectors, our team at Lompostran have the technical expertise and industry know-how to provide tailored, Cannabis derived Active Pharmaceutical Ingredients (APIs).
Operating a state of the art, GMP compliant manufacturing facility just outside Lisbon, Lompostran is a safe, reliable and cost-effective contract manufacturing partner, providing confidence to our clients of delivering high quality Cannabis derived products to market.
We pair our expertise with your vision to bring your products to the patient.
Licence Formally Submitted
Our licence application has been formally submitted to Infarmed for MIA and GMP certification and we look forward to receiving Infarmed at our facility for our GMP inspection, and working closely with them in the months ahead, to finalise our...
Acquisition of our GMP facility
Our parent company, Atann Holdings, has successfully completed the acquisition of a previously certified pharmaceutical manufacturing facility. The design, installation and qualification of minor modifications to the building are almost complete. This has allowed Lompostran to start sourcing and qualifying...
GMP license submitted to Infarmed
Lompostran has established a robust quality management system and all of the necessary support processes in order to achieve our objectives of producing safe, efficacious and quality products. Having submitted our application for all necessary manufacturing licenses, we now look...